We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$11B
AUM Growth
-$362M
Cap. Flow
-$119M
Cap. Flow %
-1.08%
Top 10 Hldgs %
49.68%
Holding
561
New
34
Increased
69
Reduced
156
Closed
27

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$67.3M
2
CSL icon
Carlisle Companies
CSL
+$32.3M
3
META icon
Meta Platforms (Facebook)
META
+$21.6M
4
INTU icon
Intuit
INTU
+$10.1M
5
VEEV icon
Veeva Systems
VEEV
+$6.06M

Top Sells

Rank Stock Value
1
ROP icon
Roper Technologies
ROP
+$43.9M
2
ADBE icon
Adobe
ADBE
+$24.7M
3
FISV
Fiserv Inc
FISV
+$24.2M
4
AMT icon
American Tower
AMT
+$16.2M
5
PAYC icon
Paycom
PAYC
+$15.6M

Sector Composition

Rank Sector Weight
1 Technology 34.23%
2 Healthcare 16.4%
3 Consumer Discretionary 12.26%
4 Communication Services 11.59%
5 Financials 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWONK icon
451
Liberty Media Series C
FWONK
$26.1B
$29.6K ﹤0.01%
332
VSTM icon
452
Verastem
VSTM
$627M
$29.3K ﹤0.01%
4,500
-1,449
-24% -$12.9K
QSR icon
453
Restaurant Brands International
QSR
$26.9B
$29.2K ﹤0.01%
+432
New +$29.8K
CME icon
454
CME Group
CME
$95.1B
$28.4K ﹤0.01%
100
AAXJ icon
455
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.86B
$28.2K ﹤0.01%
276
+1
+0.4% +$93
BABA icon
456
Alibaba
BABA
$295B
$28K ﹤0.01%
162
AMLX icon
457
Amylyx Pharmaceuticals
AMLX
$2.61B
$27.9K ﹤0.01%
1,803
MIRM icon
458
Mirum Pharmaceuticals
MIRM
$6.06B
$27.6K ﹤0.01%
+278
New +$20K
AGG icon
459
iShares Core US Aggregate Bond ETF
AGG
$138B
$27.3K ﹤0.01%
+272
New +$27.3K
ONON icon
460
On Holding
ONON
$10.3B
$26.9K ﹤0.01%
590
PEO
461
Adams Natural Resources Fund
PEO
$769M
$26.5K ﹤0.01%
1,108
IBB icon
462
iShares Biotechnology ETF
IBB
$9.84B
$26.5K ﹤0.01%
150
BAX icon
463
Baxter International
BAX
$14B
$24K ﹤0.01%
1,225
HUM icon
464
Humana
HUM
$46.2B
$23.9K ﹤0.01%
115
-50
-30% -$13.1K
ACWI icon
465
iShares MSCI ACWI ETF
ACWI
$33.7B
$23.5K ﹤0.01%
+160
New +$22.5K
BNTX icon
466
BioNTech
BNTX
$23.2B
$22.7K ﹤0.01%
190
CYBR
467
DELISTED
CyberArk
CYBR
$22.3K ﹤0.01%
50
BF.B icon
468
Brown-Forman Class B
BF.B
$12.9B
$21.4K ﹤0.01%
799
-3,657
-82% -$103K
FMS icon
469
Fresenius Medical Care
FMS
$12.6B
$20.8K ﹤0.01%
926
RUN icon
470
Sunrun
RUN
$2.35B
$20.7K ﹤0.01%
1,000
OXY.WS icon
471
Occidental Petroleum Corp Warrants
OXY.WS
$33.3B
0
RACE icon
472
Ferrari
RACE
$72.2B
$20.2K ﹤0.01%
+60
New +$24K
DUK icon
473
Duke Energy
DUK
$97B
$20.2K ﹤0.01%
168
KD icon
474
Kyndryl
KD
$2.9B
$19.7K ﹤0.01%
828
REAL icon
475
The RealReal
REAL
$1.35B
$19.3K ﹤0.01%
1,202

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Loring Wolcott & Coolidge Fiduciary Advisors held 561 positions worth $11B, down 3.2% from $11.4B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2025 filing shows 34 new, 69 increased, 156 reduced and 27 closed positions. Its largest new stake was Alpha Architect US Equity 2 ETF: 43,122 shares worth $2.15M. The largest sale was Roper Technologies, an estimated $43.9M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2025 buy was Alpha Architect US Equity 2 ETF: 43,122 shares worth $2.15M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Qualcomm in Q4 2025, an estimated $67.3M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2025 reduction was Roper Technologies, cutting an estimated $43.9M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Fair Isaac in Q4 2025, selling an estimated $1.26M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 50% of its $11B portfolio in Q4 2025.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 34 new positions and closed 27 in Q4 2025.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 3.2% quarter-over-quarter to $11B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2025, filed 28 Jan 2026.